ITP during Pregnancy

EHA Library, Nichola Cooper, 274169

MRD in MM

EHA Library, Stefania Oliva, 274166

EHA Education and Mentoring Awards 2019

EHA Library, Irene Roberts, 277209

EHA Education and Mentoring Awards 2019

EHA Library, Shaun McCann, 277208

Iron homeostasis in host defense and inflammation

EHA Library, Elizabeta Nemeth, 273539

Jean Bernard Lifetime Achievement Award Lecture

EHA Library, Wim Fibbe, 273538

Neuronal regulation of normal and malignant bone morrow niches

EHA Library, Simón Méndez-Ferrer, 273537

CHANGE IN CLONE SIZE DOES NOT PREDICT RISK OF MAJOR ADVERSE VASCULAR EVENTS: RESULTS FROM THE INTERNATIONAL PNH REGISTRY

EHA Library, Philippe Gustovic, 267448

DYNAMIC GENETIC EVOLUTION IN MYELODYSPLASTIC SYNDROME AND THE CLINICAL IMPLICATIONS

EHA Library, Yu Jen Lin, 267424

HNRNP K LEVELS PREDICT FOR POOR CLINICAL RESPONSES IN DLBCL AND REPRESENT A NOVEL THERAPEUTIC TARGET

EHA Library, Sean Post, 267429

TARGETING ABERRANT DNA METHYLATION AS A NOVEL AND UNIFORM THERAPEUTIC STRATEGY FOR THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA

EHA Library, Morgan Thénoz, 267443

AZACITIDINE AND ASCORBATE INHIBIT COMPETITIVE OUTGROWTH OF HUMAN TET2-MUTANT HSPCS IN A XENOGRAFT MODEL OF PRE-LEUKEMIA

EHA Library, Yusuke Nakauchi, 267419

A PHASE 2A STUDY OF THE LSD1 INHIBITOR IMG-7289 FOR THE TREATMENT OF MYELOFIBROSIS

EHA Library, Kristen Pettit, 267415

NIVOLUMAB AND BRENTUXIMAB VEDOTIN-BASED, RESPONSE-ADAPTED TREATMENT IN PRIMARY REFRACTORY AND IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN CHECKMATE 744

EHA Library, Thierry LeBlanc, 267405

ALTERATION OF IRON HOMEOSTASIS IN A MOUSE MODEL OF LIVER-STAGE PLASMODIUM INFECTION

EHA Library, Francesca Vinchi, 267439

A FULLY HUMAN BISPECIFIC ANTIBODY FUNCTIONALLY RESCUES FACTOR VIII DEFICIENCY EX VIVO

EHA Library, Wei Wang, 267434

CLINICAL RESPONSES AND PHARMACOKINETICS OF FULLY HUMAN BCMA TARGETING CAR T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Chunrui Li, 267410

GENOME-WIDE CRISPR-CAS9 SCREEN REVEALS SYNTHETIC LETHALITY OF WNT PATHWAY ACTIVATION AND ASPARAGINASE IN DRUG-RESISTANT ACUTE LEUKEMIAS

EHA Library, Laura Hinze, 267332

IMPROVED EFFICACY AND SAFETY OF A DUAL-TARGET CAR-T CELL THERAPY TARGETING BCMA AND CD38 FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM A PHASE I STUDY

EHA Library, Heng Mei, 267409

EVALUATION OF AMG 420, AN ANTI-BCMA BISPECIFIC T-CELL ENGAGER (BITE®) IMMUNOTHERAPY, IN R/R MULTIPLE MYELOMA (MM) PATIENTS: UPDATED RESULTS OF A FIRST-IN-HUMAN (FIH) PHASE 1 DOSE ESCALATION STUDY

EHA Library, Max Topp, 267408

IMR-687, A HIGHLY SELECTIVE PHOSPHODIESTERASE 9 INHIBITOR (PDE9I), DEMONSTRATES PRELIMINARY EVIDENCE OF ACTIVITY ON RED AND WHITE CELL BIOMARKERS IN A PH-2A INTERIM ANALYSIS

EHA Library, Biree Andemariam, 267437

TCD IMPLEMENTATION RATES AND RESULTS IN THE MODERN ERA OF SICKLE CELL ANEMIA: RESULTS FROM THE DISPLACE STUDY

EHA Library, Julie Kanter, 267438

AVAPRITINIB, A POTENT AND SELECTIVE INHIBITOR OF KIT D816V, INDUCES COMPLETE AND DURABLE RESPONSES IN PATIENTS (PTS) WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM)

EHA Library, Deepti Radia, 267413

CPI-0610, A BROMODOMAIN AND EXTRATERMINAL DOMAIN (BET) INHIBITOR, REDUCES PRO-INFLAMMATORY CYTOKINES, BONE MARROW FIBROSIS AND THE NUMBER OF TRANSFUSIONS IN MYELOFIBROSIS PATIENTS

EHA Library, Ronald Hoffman, 267414

NIVOLUMAB PLUS DOXORUBICIN, VINBLASTINE AND DACARBAZINE FOR NEWLY DIAGNOSED ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: 2-YEAR EXTENDED FOLLOW-UP FROM COHORT D OF THE PHASE 2 CHECKMATE 205 STUDY

EHA Library, Eva Domingo Domènech, 267404

SAFETY AND EFFICACY OF AN ANTI-FCRN ANTIBODY, ROZANOLIXIZUMAB, IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: INTERIM RESULTS OF A PHASE II, MULTIPLE-DOSE STUDY

EHA Library, Tadeusz Robak, 267433

TNF-Α BLOCKADE CORRECTS THE MONOCYTE/MACROPHAGE IMBALANCE IN PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)

EHA Library, Yajing Zhao, 267432

MASS CYTOMETRY REVEAL EARLY SIGNALING RESPONSES TO INDUCTION THERAPY IN IMMUNOPHENOTYPICALLY DEFINED LEUKEMIC CELL SUBSETS THAT PREDICT SURVIVAL IN AML

EHA Library, Benedicte Tislevoll, 267418

FRONTLINE BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY FOR STAGE 3/4 CLASSICAL HODGKIN LYMPHOMA: 3-YEAR UPDATE OF THE ECHELON-1 STUDY

EHA Library, Andrea Gallamini, 267403

ONE-YEAR EFFICACY OF RAVULIZUMAB (ALXN1210) IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA NAIVE TO COMPLEMENT INHIBITORS

EHA Library, Hubert Schrezenmeier, 267446

PREDICTED NEOANTIGENS PROVIDE PROGNOSTIC INSIGHT IN DLBCL

EHA Library, Sally Trabucco, 267428

PHASE II STUDY OF ORAL RIGOSERTIB COMBINED WITH AZACITIDINE IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (MDS)

EHA Library, Michael E. Petrone, 267422

IMPACT OF 1ST LINE TREATMENT ON OVERALL SURVIVAL IN 1.633 PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA - A MULTINATIONAL COLLABORATIVE EFFORT COORDINATED BY THE AGMT STUDY GROUP

EHA Library, Lisa Pleyer, 267423

A PHASE 2 OPEN-LABEL PROOF OF CONCEPT STUDY OF THE ORAL, SMALL MOLECULE FACTOR D INHIBITOR, ACH-4471, IN UNTREATED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

EHA Library, Peter Browett, 267447

KDM5 INHIBITION OFFERS A NOVEL THERAPEUTIC STRATEGY FOR THE TREATMENT OF KMT2D MUTANT LYMPHOMAS

EHA Library, James Heward, 267427

THE PROLIFERATIVE HISTORY SHAPES THE DNA METHYLOME OF B-CELL TUMORS AND PREDICTS CLINICAL OUTCOME

EHA Library, Martí Duran-Ferrer, 267426

TRANSFUSION DEPENDENCY IS ASSOCIATED WITH PRESENCE OF TOXIC IRON SPECIES AND INFERIOR SURVIVAL IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Marlijn Hoeks, 267421

ALLELIC POLYMORPHISM OF PLATELET GLYCOPROTEIN GENES GPIA AND GPIIB AS A POSSIBLE PREDICTIVE MARKER OF RESPONSE TO THERAPY IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA

EHA Library, Irina Zotova, 267431

PEGCRISANTASPASE AND VENETOCLAX COMBINATION IS HIGHLY EFFECTIVE AGAINST ACUTE MYELOID LEUKEMIA (AML), MECHANISTICALLY DRIVEN SYNERGISM BETWEEN GLUTAMINE DEPLETION AND BCL-2 INHIBITION

EHA Library, Ashkan Emadi, 267417

SOTATERCEPT (ACE-011) IN SUBJECTS WITH MPN-ASSOCIATED MYELOFIBROSIS AND ANEMIA

EHA Library, Prithviraj Bose, 267412

THE ROLE OF GATA2 IN HSC GENERATION THROUGH ENDOTHELIAL-TO-HEMATOPOIETIC TRANSITION.

EHA Library, Cansu Koyunlar, 267445

SUCCESSOR: A MULTICENTER RETROSPECTIVE NONINTERVENTIONAL FOLLOW-UP STUDY IN PATIENTS WITH SICKLE CELL PAIN CRISES WHO PREVIOUSLY PARTICIPATED IN THE SUSTAIN TRIAL IN THE UNITED STATES

EHA Library, Darla Liles, 267436

PET AFTER 2 CYCLES OF ABVD IN PATIENTS WITH EARLY-STAGE FAVORABLE HODGKIN LYMPHOMA TREATED WITHIN THE PHASE 3 GHSG HD16 STUDY

EHA Library, Michael Fuchs, 267402

A PHASE 3 RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY OF ISATUXIMAB, POMALIDOMIDE, AND LOW-DOSE DEXAMETHASONE VS POMALIDOMIDE AND LOW-DOSE DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Paul Richardson, 267407

SUZ12 INACTIVATION COOPERATES WITH JAK3 MUTANT SIGNALING TO DRIVE T-ALL DEVELOPMENT

EHA Library, Michael Broux, 267441

Do our expectations for CAR T cell therapy outweigh the facts? Patient Perspectives on CAR-T gaps and challenges

EHA Library, Brian Koffman, 274193

Microbiota and GvHD development: a double edge sword

EHA Library, Ernst Holler, 274192

The role of epigenomics to diagnose and estimate prognosis in lymphoid neoplasms

EHA Library, Iñaki Martin-Subero, 274191

The role of epigenomics to diagnose and estimate prognosis in lymphoid neoplasms

EHA Library, Iñaki Martin-Subero, 274243

THE NUCLEOTIDE KINASE NADK CONSTITUTES A METABOLIC VULNERABILITY OF NOTCH1-DRIVEN T-ALL

EHA Library, Etienne De Braekeleer, 267440

RANDOMIZED, OPEN-LABEL, NON-INFERIORITY, PHASE 3 STUDY OF SUBCUTANEOUS (SC) VERSUS INTRAVENOUS (IV) DARATUMUMAB (DARA) ADMINISTRATION IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: COLUMBA

EHA Library, María-Victoria Mateos, 267406

A RANDOMIZED, DOUBLE BLIND PHASE 2 STUDY OF 3 DIFFERENT DOSES OF PRM-151 IN PATIENTS WITH MYELOFIBROSIS WHO WERE PREVIOUSLY TREATED WITH OR INELIGIBLE FOR RUXOLITINIB

EHA Library, Srdan Verstovsek, 267411

LOSS OF THE F-BOX PROTEIN NIPA CAUSES BONE MARROW FAILURE

EHA Library, Stefanie Kreutmair, 267444

IN VIVO SELECTION FOR CORRECTED BETA-GLOBIN ALLELES AFTER CRISPR/CAS9 EDITING IN HUMAN SICKLE HEMATOPOIETIC STEM CELLS ENHANCES THERAPEUTIC POTENTIAL

EHA Library, Mark WALTERS, 267435

PRIMARY THERAPY AND SURVIVAL AMONG ADULT PATIENTS WITH NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA (NLPHL): A POPULATION-BASED ANALYSIS IN THE NETHERLANDS, 1993-2016

EHA Library, Hidde Posthuma, 267401

THE SINGLE-CELL ATLAS OF DRIVER MUTATIONS IN AML

EHA Library, Kiyomi Morita, 267416

MODELING MANTLE CELL LYMPHOMA IN MICE

EHA Library, Tim Pieters, 267425

DISTINCT AND COMMON DEREGULATED PATHWAYS IN RUNX1, GATA1 AND GFI1B ASSOCIATED BLEEDING DISORDERS

EHA Library, Maaike van Bergen, 267430

TREATMENT WITH IMETELSTAT PROVIDES DURABLE TRANSFUSION INDEPENDENCE (TI) IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER RISK MDS (LR-MDS) RELAPSED/REFRACTORY (R/R) TO ERYTHROPOIESIS STIMULATING AGENTS (ESAS)

EHA Library, Pierre Fenaux, 267420

NGS technologies in AML: Time to use in clinical care?

EHA Library, Torsten Haferlach, 274187

Impact of social stigma on coping with SCD

EHA Library, Kofi Anie, 274186

Pathophysiology and therapeutic targets in acquired aplastic anemia: Inferences from immunosuppression and stem cell stimulation

EHA Library, Neal Young, 274183

Iron homeostasis in host defense and inflammation

EHA Library, Elizabeta Nemeth, 274182

Neuronal regulation of normal and malignant BM niches

EHA Library, Simón Méndez-Ferrer, 274181

Immunobiology of MSCs

EHA Library, Wim Fibbe, 274165

CAR T cells for lymphoma/ALL: CD19 and beyond

EHA Library, Ulrich Jäger, 274153

CAR-T cells in acute leukaemia

EHA Library, Mohamad Mohty, 274162

Stem cells in steady state and under stress

EHA Library, Elisa Laurenti, 274160

Somatic mutations in aplastic anemia: Significance for classification, therapy, and outcome

EHA Library, Judith Marsh, 273661

Immunosuppression and stem cell stimulation to treat AA: Clinical and biologic implications

EHA Library, Neal Young, 273662

Stem cell transplantation in aplastic anemia: Impact on choices for first line therapy

EHA Library, Andrea Bacigalupo, 273663

The diagnostic potential of the iron regulatory hormone hepcidin

EHA Library, Andrew Armitage, 273688

Mechanisms, mishaps and manipulation of iron uptake

EHA Library, Sant-Ryan Pasricha, 273689

Novel approaches to oral iron treatment

EHA Library, Diego Moretti, 273690

Bone marrow niche in multiple myeloma and its precursor states

EHA Library, Irene Ghobrial, 273694

Minimal residual disease (MRD) in multiple myeloma: Prognostic and therapeutic implications (including imaging)

EHA Library, Roger Owen, 273695

Front-line treatment of multiple myeloma

EHA Library, Michele Cavo, 273696

Medical management of acute responses to radiation

EHA Library, Nelson Chao, 273706

Microbiota and GvHD: A double edged sword

EHA Library, Ernst Holler, 273707

Unmanipulated Haploidentical transplantation for adult patients with hematological malignancies

EHA Library, Annalisa Ruggeri, 273708

Combining novel agents in chronic lymphocytic leukemia: Greater than the sum of its parts?

EHA Library, Arnon Kater, 273672

Mechanisms of resistance to targeted therapies in chronic lymphocytic leukemia

EHA Library, Lesley-Ann Sutton, 273671

Genetic predisposition to chronic lymphocytic leukemia

EHA Library, Richard Houlston, 273670

Direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer

EHA Library, Guy Meyer, 273666

Screening for cancer in unprovoked venous thromboembolism

EHA Library, Marc Carrier, 273665

Mechanisms of cancer-associated thrombosis

EHA Library, Christophe Dubois, 273664

Prediction of recurrence after unprovoked VTE

EHA Library, Sabine Eichinger, 274207

Transfusion

EHA Library, Marianne de Montalembert, 274208

Added value of blood monitoring of CTCs vs. bone marrow MRD in multiple myeloma

EHA Library, Alberto Orfao, 274210

CAR T cell therapy for multiple myeloma

EHA Library, Andrew Garfall, 273524

CARs for acute myeloid leukemia

EHA Library, Michael Hudecek, 273523

MLL-AF4 CAUSES ABERRANT UPREGULATION OF PROM1 (CD133) IN ACUTE LYMPHOBLASTIC LEUKEMIA BY CONTROLLING ENHANCER-PROMOTER INTERACTIONS

EHA Library, Thomas A Milne, 265943

XBP1 PROMOTES PRE-B CELL ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH OF IL-7 RECEPTOR SIGNALING IN MICE

EHA Library, Azam Salimi, 265942

COMBINATION OF FLOTETUZUMAB, A CD123 X CD3 BISPECIFIC DART® MOLECULE, AND BLINATUMOMAB, A CD19 X CD3 BITE MOLECULE, TO PREVENT ANTIGEN ESCAPE IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Dragana Slavkovic Lukic, 265945

SINGLE-CELL TRANSCRIPTIONAL HETEROGENEITY SUGGESTS NOVEL FINGERPRINT OF RELAPSE IN ACUTE MYELOID LEUKEMIA

EHA Library, Cheng ZHANG, 265946

THERAPEUTIC TARGETING OF CYTOKINE INDUCED PIM1 ACTIVATION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA

EHA Library, Renate De Smedt, 265947

TARGETING ONCOGENIC NOTCH1 IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH A NEW SELECTIVE SERCA INHIBITOR CAD204520

EHA Library, Matteo Marchesini, 265948

COMBINATION OF SELECTIVE GAMMA-SECRETASE INHIBITOR MRK-560 WITH OTHER TARGETED THERAPY IS AN EFFECTIVE AND SAFE TREATMENT FOR T-ALL

EHA Library, Inge Govaerts, 265949

RAS/MAPK ACTIVATION COOPERATES WITH GAIN OF CHROMOSOME 21 IN B CELL LEUKEMIA AND IS AN ATTRACTIVE TARGET TO IMPROVE THE OUTCOME OF DS CHILDREN WITH B-ALL

EHA Library, Anouchka Laurent, 265941

ADAM28 OVEREXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA PROMOTE ITS INVASION IN CENTRAL NEURAL SYSTEM VIA CROSS TALKING WITH CXCR4 PATHWAY

EHA Library, Chencong Wang, 265940